MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

BioMarin Pharmaceutical Company Profile (NASDAQ:BMRN)

Consensus Ratings for BioMarin Pharmaceutical (NASDAQ:BMRN) (?)
Ratings Breakdown: 3 Hold Rating(s), 18 Buy Rating(s)
Consensus Rating:Buy (Score: 2.86)
Consensus Price Target: $140.94 (3.00% upside)

Current Analysts' Coverage Summary for BioMarin Pharmaceutical (NASDAQ:BMRN)
Show:
DateFirmActionRatingPrice TargetActions
6/29/2015Robert W. BairdReiterated RatingHold$133.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/26/2015WedbushReiterated RatingNeutral$130.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/23/2015NomuraSet Price TargetBuy$163.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/19/2015William BlairBoost Price TargetOutperform$126.00 -> $140.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/18/2015Cowen and CompanyReiterated RatingOutperform$150.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/18/2015Canaccord GenuityBoost Price TargetBuy$115.00 -> $150.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/18/2015SunTrustBoost Price TargetBuy$151.00 -> $170.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/18/2015Deutsche BankBoost Price TargetBuy$140.00 -> $156.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/18/2015Jefferies GroupBoost Price TargetBuy$135.00 -> $150.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/18/2015BarclaysBoost Price TargetOverweight$150.00 -> $156.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/18/2015JPMorgan Chase & Co.Boost Price TargetOverweight$140.00 -> $151.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/18/2015Piper JaffrayBoost Price TargetOverweight$123.00 -> $147.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/18/2015RBC CapitalBoost Price TargetOutperform$125.00 -> $145.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/18/2015Leerink SwannBoost Price Target$143.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/26/2015Brean CapitalReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/26/2015Citigroup Inc.Reiterated RatingBuy$94.00 -> $133.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/9/2015Bank of AmericaInitiated CoverageBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/29/2015Evercore ISIInitiated CoverageBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/10/2014Goldman SachsUpgradeNeutral -> Buy$78.00 -> $104.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/3/2014Wells Fargo & Co.UpgradeMarket Perform -> OutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/27/2014Credit SuisseReiterated RatingOutperform$74.00 -> $75.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/21/2014Ned Davis ResearchUpgradeSell -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/22/2013HSBCBoost Price TargetOverweight$46.00 -> $50.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/18/2013Stifel NicolausDowngradeBuy -> Hold$70.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/4/2013 forward)